|
NATIONAL CANCER RESEARCH MONTH
|
May is National Cancer Research Month
This month, the Case Comprehensive Cancer Center  (Case CCC) is supporting the global awareness campaign highlighting the importance of cancer research.
According to the American Association for Cancer Research (AACR), more than 16.9 million people in the United States and millions more worldwide are cancer survivors who are living with, through, and beyond their disease thanks to spectacular advances in cancer research.
This year's National Cancer Research Month theme is "Bringing Cancer Research to Life." Though significant strides have been made, the toll of cancer is still a growing public health challenge. We know that together, we can defeat cancer.
You can join us in this campaign by sharing how you bring cancer research to life through your work by
submitting a feature to the Case CCC communications team or engaging in the campaign on social media with hashtags
#NCRM19 and
#ResearchSavesLives. Don't forget to tag us
@CaseCCC on so we can share as well!
|
"The Race" 5K and 1-Mile Run Benefits Breast Cancer Research on Mother's Day, May 12
The 16th annual family-friendly "The Race" will take place this Mother's Day, Sunday, May 12, at Legacy Village in Lyndhurst. Registration begins at 7:30 am and the 5K starts at 8:30 am, followed by the 1-mile run at 9:30 am.
The goal of "The Race" is to empower children and
their families to make a difference in the lives of those touched by breast cancer. Participants will receive a commemorative t-shirt and all guests will enjoy refreshments, bounce houses, laser tag, face painting and more. Prizes will be awarded to the team and school with the greatest participation, and well as the individual who raises the most money.
This year's event will honor two inspiring women and breast cancer survivors from
Case Western Reserve University School of Medicine. Dean
Pamela B. Davis, MD, PhD, who is a renowned physician researcher and the medical school's fearless leader, and associate professor
Nicole Ward, PhD, who has obtained national and international recognition and funding for her dermatology research.
For the past 15 years, "The Race" has attracted thousands of participants each Mother's Day. Private donors cover the operating costs of the event, and 100 percent of participants' registration fees and donations will be given to the
Case Comprehensive Cancer Center (Case CCC) in support of innovative breast cancer research.
"Our investigators are consistently working towards finding cancer cures, and thanks to 'The Race' they will be supported through availability of new pilot grant awards," said Case CCC Director
Stan Gerson, MD. "It's inspiring to see cancer research advocates join together in our Cleveland community. The event organizers are bringing an engaged community to an exciting event that will benefit all individuals and families affected by cancer."
more>
|
Ice Cream Sundae Bar Benefitting VeloSano Team Case CCC
May 3, 1-3p | BRB Lobby
The ice cream sundae bar is back today,
this time in the BRB lobby. Stop by between 1-3pm, and build your own sundae for just a $5 donation. Cash and Venmo will be accepted.
|
Scott Lab Recruiting Technician
The lab of
Jacob Scott, MD, PhD in the Cleveland Clinic Lerner Research Institute's Theory Division is seeking a bachelor's or master's level lab technician to assist in studying cancer evolution and antibiotic resistance.
A great candidate would have (or almost have) a BS in an applied science, be curious, like working in teams, be inclusive and eager to work in a diverse community. The job will be mostly wet lab with some light management type work too.
In case you missed it, his
Twitter sales pitch for the role was quite entertaining! Visit
the lab website to learn more or
contact Scott for more information.
|
19th Annual Jerome I. Kleinerman, MD Lecture in Pulmonary Pathobiology
May 3, 4p | WRB Auditorium
The Department of Pathology will be hosting The 19th Annual Jerome I. Kleinerman, MD Lecture in Pulmonary Pathobiology on Friday, May 3, 2019 at 4 pm in the Wolstein Research Building Auditorium.
Philip T. Cagle, MD, professor of pathology at
the Weill
Medical School of Cornell University and S. Donald Greenberg Chair and Director of Pulmonary Pathology at Houston Methodist Hospital in Houston, TX, will be presenting, "Approach to the Lung Cancer Biopsy for Molecular Testing in the Context of the New Guidelines".
A wine reception will be held in the WRB lobby immediately following the lecture. All are welcome to attend.
|
Fellowship Writing 101
May 9, 12p | WRB 3-136
To help trainees prepare competitive applications,  William Schiemann, PhD, Chair of the NCI fellowship review panel, will present "Fellowship Writing 101" on Thursday, May 9 in WRB conference room 3-136 at 12 pm. Free lunch will be provided for those that RSVP to Damian Junk at
damian.junk@case.edu
. An NCI-style review panel will include Case CCC Trainee Associate Members as reviewers to provide insight into the review process.
|
Cancer Center Seminar Series: "Prediction and Prevention of Treatment-Related Adverse Effects in Cancer Survivors"
May 10, 12p | WRB Auditorium
Our weekly seminar will be back
next Friday in the Wolstein Research
 Building Auditorium. Join us at noon to hear
Smita Bhatia, MD, MPH present, "
Prediction and Prevention of Treatment-Related Adverse Effects in Cancer Survivors."
Dr. Bhatia is visiting us from the School of Medicine at the University of Alabama at Birmingham. There she is the Gay and Bew White Endowed Chair in Pediatric Oncology, professor of pediatric oncology, Vice Chair for Outcomes Research in the Department of Pediatrics, and Director of the Institute for Cancer Outcomes and Survivorship.
The Seminar Series
will
be
available to view via live stream. While we highly encourage you to attend in person to interact with our speakers and receive CME credit, we understand that may not always be possible. Presentations will not be recorded for later viewing, but you may watch the seminar in real time and ask questions via chat.
Watch live at noon>
|
Cancer Center Seminar Series: Special Presentation: Helen Moss Integrative Oncology Lecture
May 17, 12p | WRB Auditorium
The final weekly seminar of the 2018-2019 series will be held Friday, May 17 in the Wolstein Research
 Building Auditorium. Join us at noon to hear
Peiying Yang, MS, PhD present, "Natural Products for the Development of Novel Anticancer Therapies.
"
Dr. Yang is associate professor in the Department of Palliative, Rehabilitation and Integrative Medicine, Division of Cancer Medicine at The University of Texas MD Anderson Cancer Center. Her research examines the effects of traditional Chinese medicine, natural products and dietary supplements
for treatment or prevention of cancer and symptom management.
|
Opportunities for Pilot Projects in Catchment-Related Cancer and Risks
Deadline for specific aims: May 27, 2019
Deadline for full proposal: June 21, 2019
The Case Comprehensive Cancer Center is providing
seed funding for highly innovative and impactful laboratory-based proposals focused on catchment-related cancers and risks prevalent in underserved populations. Results from this pilot are expected to provide key findings to support larger, nationally competitive grants. Only members of the Molecular Oncology, GU Malignancies, Developmental Therapeutics, Hematopoietic and Immune Biology or Cancer Imaging Programs are eligible to serve as lead PIs for this pilot award. Attention to research relevant to our catchment area is a cross-cutting theme of the Case CCC scientific programs; thus projects aligned with the Center's strategic plan that focus on the major cancers of our catchment area, in particular those with excess incidence, morbidity, mortality or risks of cancers due to local environment, lifestyle, socioeconomic, special population factors will be prioritized. Collaborative, multi-investigator projects are particularly encouraged, especially those linking laboratory- and population-based researchers. more>
|
Doris Duke 2019 Sickle Cell Disease/Advancing Cures Award
Deadline: May 31, 2019
The Doris Duke Sickle Cell Disease/Advancing Cures
award provides grants to advance curative approaches for sickle cell disease, including gene modification and drug therapies to restore hemoglobin function.
This award aims to support clinical research that will:
- Advance gene therapies for sickle cell disease into the clinic, including gene addition and genome editing.
- Build on globin regulatory mechanisms to restore red blood cell function.
- Advance bone marrow transplant approaches to minimize toxicities and improve outcomes.
In keeping with the wishes expressed in Doris Duke's will, experiments that use animals or primary tissues derived from animals will not be supported by this program. The number of funded projects will depend on the number of meritorious applications received and their budgets. Flexible annual direct cost amounts of $150,000 - $300,000 will be considered, plus an annual 10% indirect cost allowance.
View the complete RFA>
Doris Duke 2019 Physician Scientist Fellowship
Deadline: June 7, 2019
The Doris Duke Physician Scientist Fellowship program provides grants to physician scientists at the subspecialty fellowship level who are seeking to conduct additional years of research beyond their subspecialty requirement. The goal is to aid in the transition into a research faculty appointment.
The Physician Scientist Fellowship consists of $100,000 for annual direct costs plus $10,000 (10 percent) for annual indirect costs for one or two years, depending on the need of the applicant. The priority of the Physician Scientist Fellowship program is to fund outstanding individuals with excitement for clinical research careers, whose projects will address highly significant research questions and lead to career advancement. DDCF does not have funding priorities for this fellowship based on disease area or research type.
View the complete RFA>
|
Pediatric Brain Tumor Foundation Early Career Development Grants
Deadline: June 7, 2019
The Pediatric Brain Tumor Foundation's multi-year Early Career Development grants support rising stars in research, seeding the field for future pediatric brain tumor discovery. Recent awards have led to progress in medulloblastoma and neuro-epidemiology research and helped leverage additional research funding.
The goal of the PBTF's Early Career Development program is to support talented researchers in the field of pediatric brain tumors who are in the first five years of their first faculty position. The expectation is that this funding (up to $300,000 total over 3 years) will facilitate awardees' transition to becoming fully independent investigators. The research proposed for funding must focus on pediatric brain tumors. Projects may be discovery-oriented, translational or epidemiological in nature. more>
|
VeloSano Catalyst Fellowship
Deadline: June 7, 2019
With the generous support from VeloSano Bike to Cure  2018, the Case CCC is providing seed funding for Case CCC Trainee Associate Members to perform their "dream experiment." Up to 5 research projects may be funded at $10,000 per award which must be completed within 1 year.
The experiment should catalyze highly innovative and impactful projects and help strengthen fellowship and career development grant applications. The intent of the award is to support a single or limited set of innovative experiments, not for general laboratory supplies/projects or maintenance of the trainee's project.
more>
|
Opportunities for Developmental Research Proposals in Translational Cancer Disparities Research
Deadline:
June 30, 2019
The Case Comprehensive Cancer Center's P20 SPORE
(
Feasibility and Planning Study for the Development of Specialized Programs of Research Excellence to Investigate Cancer Health Disparities
) is providing seed funding for highly innovative disparities-focused proposals that will generate key data for a future P50 application under the umbrella of the National Cancer Institute (NCI) "Specialized Programs of Research Excellence (SPOREs)." The P20 pilot grants will support feasibility and planning activities to build comprehensive cancer health disparities research programs. All applications must propose translational research that will contribute to improved prevention, early detection, diagnosis, and/or treatment of cancers found to disproportionately affect populations who experience cancer health disparities. DRPs need not reach a human endpoint during the proposed project period, yet must have clearly defined translational potential. Proposals must clearly demonstrate the relevance to cancer outcome disparities. more>
|
Health Imaging - Apr 18, 2019
"The idea is simple: assess digital images and determine which slides are worthy for analysis by a computer and which are not," said Anant Madabhushi, PhD, director of CWRU's Center for Computational Imaging and Personalized Diagnostics and member of the Case CCC's Cancer Imaging Program.
Getting to Know Our Patients
The New York Times - Apr 24, 2019
Mikkael Sekeres, MD, director of the leukemia program at the Cleveland Clinic, shares a trainee story in his latest contribution to the NY Times. Dr. Sekeres is the Deputy Associate Director for Clinical Research at the Case CCC. |
NIH BULLETIN - Notices and Funding Opportunities
|
|
|
Have news or updates to share?
Contact our communications team at
|
EVENTS
|
|
Fri, May 3
Taussig Cancer Institute Grand Rounds
Laura Dawson, MD
Princess Margaret Cancer Center
"Increasing Role of Radiotherapy for Primary and Metastatic Liver Cancer"
8a CA5-120
*No Cancer Center Seminar Series*
2019 Great Lakes Breast Cancer Research Symposium
Details
$5 Ice Cream Sundae Bar VeloSano Fundraiser for Team Case CCC
1-3p BRB Lobby
19th Annual Jerome I. Kleinerman, MD Lecture in Pulmonary Pathobiology
Philip T. Cagle, MD
Professor of Pathology
Weill Medical School of Cornell University
S. Donald Greenberg Chair and Director, Pulmonary Pathology
Houston Methodist Hospital
"
Approach to the Lung Cancer Biopsy for Molecular Testing in the Context of the New Guidelines"
4p WRB Auditorium
|
|
Mon, May 6
Cancer Center Research Chalk Talk
1p WRB 3-136
Tumor Immunology and Immunotherapy
Adoro
12p CA4-124
Genomic Medicine Institute
Sara Akhavanfard, MD
Eng Lab
"The Genomic Landscape of Early-onset Solid Tumors in Children, Adolescents and Young Adults"
Rumana Akhter, PhD
Bekris Lab
"The Role of TREM2 in the Microglial Response to β-amyloid"
12p NE1-205
|
|
Thurs, May 9
Developmental Therapeutics Journal Club
9a N
E
6-218
Fellowship Writing 101
12p WRB 3-136
Molecular Biology and Microbiology Seminar
1p SOM W203
|
|
Fri, May 10
Taussig Cancer Institute Grand Rounds
8a CA5-120
UH Seidman Cancer Center Grand Rounds
8a Wearn 137
Cancer Center Seminar Series
Smita Bhatia, MD, MPH
Professor & Vice Chair of Outcomes for Pediatrics
Director, School of Medicine Institute for Cancer Outcomes and Survivorship
Associate Director for Outcomes Research of the UAB Comprehensive Cancer Center
Associate Director, Center for Outcomes and Effectiveness Research and Education
University of Alabama at Birmingham School of Medicine
"Prediction and Prevention of Treatment-Related Adverse Effects in Cancer Survivors"
12p WRB Auditorium
|
|
Mon, May 13
Shared Resources Directors Meeting
12p WRB 1-422D
Cancer Center Research Chalk Talk
1p WRB 3-136
|
|
Thurs, May 16
Developmental Therapeutics Journal Club
9a NE6-218
Molecular Biology and Microbiology Virology Journal Club
1p SOM W203
|
|
Fri, May 17
Taussig Cancer Institute Grand Rounds
8a CA5-120
Innovators in Biomedical Engineering Speaker Series
Herbert Levine, PhD
Professor, Physics and Bioengineering
Northeastern University
"What is Epithelial-Mesenchymal Plasticity and Why Is It Important for Metastasis?"
11a NE1-205
Cancer Center Seminar Series: Helen Moss Integrative Oncology Lecture
Peiying Yang, MS, PhD Associate Professor Department of Palliative, Rehabilitative and Integrative Medicine Division of Cancer Medicine
The University of Texas MD Anderson Cancer Center
"Natural Products for the Development of Novel Anticancer Therapies"
12p WRB Auditorium
|
ADDITIONAL UPCOMING SYMPOSIUMS & EVENTS
"The Race" 5K/1mi walk/run 2019
May 12, 2019
Legacy Village
Race for the Place
June 2, 2019
Beachwood Place
NCCN Policy Summit
June 17, 2019
Washington, DC
Details
ASCO Review
June 26, 2019
InterContinental Hotel
|
PREVIOUSLY ANNOUNCED OPPORTUNITIES
The Mark Foundation for Cancer Research 2019 Emerging Leader Award
Deadline: May 10, 2019
Deadline: May 20, 2019
LOI/Preproposal Deadlines: May 22, 2019 and Aug 21, 2019
Deadline: May 30, 2019
Case CCC Travel Awards for Trainees
Deadlines: June 1, September 1, December 1
Deadline: June 7, 2019
2019 Postdoctoral Fellowship in Understanding Dynamic and Multi-Scale Systems
Deadline: June 13, 2019
Deadline: July 24, 2019
Deadline: July 24, 2019
Deadline: July 31, 2019
Deadline: July 31, 2019
Deadline: Open
Deadline: Open
Deadline: Open
Deadline: Open
Deadline: Open
|
|
 |
|
